Live Breaking News & Updates on Pooled analysis

Stay updated with breaking news from Pooled analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

AstraZeneca: TAGRISSO achieved unprecedented survival in early-stage EGFR-mutated lung cancer, with 88% of patients alive at five years in ADAURA Phase III trial

Treatment with adjuvant TAGRISSO reduced the risk of death by more than half Positive results from the ADAURA Phase III trial showed AstraZeneca's TAGRISSO (osimertinib) demonstrated a statistically

United-states , Cambridge , Cambridgeshire , United-kingdom , American , America , Chelsea-ford , Le-chevalier , Daiichi-sankyo , Brendan-mcevoy , Lung-ambition-alliance , World-health-organisation

Tip Sheet: Johns Hopkins Kimmel Cancer Center Researchers To Present At Asco Annual Meeting

Tip Sheet: Johns Hopkins Kimmel Cancer Center Researchers To Present At Asco Annual Meeting
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United-states , Claire-snyder , Samuel-rosner , Patrick-forde , Evan-lipson , William-sharfman , Suzanne-topalian , Benjamin-levy , Pembrolizumab-pembro , Digital-health , Association-between-real , Drug-administration

Alkermes plc: Alkermes Highlights Data From Psychiatry Portfolio at Spring 2023 Scientific Conferences

? Clinical and Patient Experience Research Delivers Insights into Treatment for People Living with Schizophrenia or Bipolar I Disorder ? DUBLIN, May 16, 2023 /PRNewswire/ -- Alkermes

Ireland , Toronto , Ontario , Canada , Ohio , United-states , Massachusetts , Miami , Florida , Athlone , Westmeath , San-francisco

HARMONY BIOSCIENCES TO PRESENT NEW WAKIX® (PITOLISANT) SAFETY AND EFFICACY DATA AT SLEEP 2023 ANNUAL MEETING

Late-breaking Phase 2 proof-of-concept study in Prader-Willi syndrome accepted for poster presentation
PLYMOUTH MEETING, Pa., May 10, 2023 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. , a... | May 10, 2023

United-states , Kumar-budur , Luis-sanay , Drug-administration , Exchange-commission , Paragon-biosciences , Prnewswire-harmony-biosciences-holdings-inc , Late-breaking-phase , Biosciences-holdings , Annual-meeting , Associated-professional-sleep-societies , Chief-medical-officer

Chance to lift lung cancer survival

Chance to lift lung cancer survival
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Australia , Flinders-university , South-australia , Ignacio-matos , Leex-li , Marka-socinski , Federico-cappuzzo , Ashleym-hopkins , Lee-li , Ashley-hopkins , Michaelj-sorich , Research-council

Eli Lilly & Co. (LLY) Reports Interim Phase 2 Data in Pediatric Patients and New Analysis from Phase 3 Program for Mirikizumab

Eli Lilly & Co. (LLY) Reports Interim Phase 2 Data in Pediatric Patients and New Analysis from Phase 3 Program for Mirikizumab
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Chicago , Illinois , Japan , Marla-dubinsky , Leonard-feinstein , Aaronm-gruver , Theresa-hunter-gibble , Brucee-sands , Eli-lilly , Jessl-kaplan , Marlac-dubinsky

Lilly Discloses First-in-Class, Interim Phase 2 Data in Pediatric Patients and New Analysis from Phase 3 Program in Adult Patients for Mirikizumab in Ulcerative Colitis

Lilly Discloses First-in-Class, Interim Phase 2 Data in Pediatric Patients and New Analysis from Phase 3 Program in Adult Patients for Mirikizumab in Ulcerative Colitis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Chicago , Illinois , United-states , Japan , American , Aaronm-gruver , Leonard-feinstein , Jessl-kaplan , Mirikizumab-pharmacokinetics , Prnewswire-eli-lilly , Marla-dubinsky , Brucee-sands

Mallinckrodt Presents Clinical Data for TERLIVAZ® (terlipressin) for Injection in Adults with Hepatorenal Syndrome (HRS) at Digestive Disease Week (DDW) 2023

/PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced the presentation of results from two clinical...

Dublin , Ireland , United-states , United-kingdom , Chicago , Illinois , American , Americans , Khurram-jamil , Derek-belz , Jasmohans-bajaj , Peter-richardson